Although this hypothesis may not work with tumor tissues where FST expression is high when compared to its normal expression such as in rodent liver tumors [50], but BRCA1 may offer a tumor suppressive function in the tumors with high activin expression such as human ovarian cancer. This evidence concerns the gene INHBE and ovarian cancer.